UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000020144
Receipt number R000023239
Scientific Title Phase I/II Study of Irinotecan and Gemcitabine in Pediatric, adolescent and Young Adult Patients with Relapsed or Refractory Solid Tumors
Date of disclosure of the study information 2015/12/11
Last modified on 2020/04/17 13:49:27

No. Disposal Last modified on Item of update
1 Insert 2015/12/10 10:04:17
2 Update 2018/12/12 11:14:42 Name of primary person or sponsor
Organization
Category of Funding Organization
3 Update 2018/12/12 11:20:26 Recruitment status
4 Update 2020/04/17 13:36:44 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/04/17 13:39:57 Number of participants that the trial has enrolled
6 Update 2020/04/17 13:49:27 Recruitment status
Date of IRB
Last follow-up date